Societal CDMO is a bi-coastal contract development and manufacturing organization (CDMO) with capabilities spanning pre-Investigational New Drug (IND) development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms with a primary focus in the area of small molecules. With an expertise in solving complex manufacturing problems, Societal is a leading CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging, and logistics services the global pharmaceutical market. 

In addition to our experience in handling DEA controlled substances and developing and manufacturing modified-release dosage forms, Societal CDMO has the expertise to deliver on our clients’ pharmaceutical development and manufacturing projects, regardless of complexity level. We do all of this in our best-in-class facilities, totaling 145,000 square feet, in Gainesville, Georgia, and San Diego, California.


Pharmaceutical

Therapeutics

Societal™ CDMO

J. David Enloe, Jr.

Carla Lusby

Matthew McKendry

Jennifer R.

Daphne Najarian

Tim Roach

Megha Nair

Julie Christian

Carol Bolger

Scott Rizzo

Richard Sidwell

The Leadership Team at Societal™ CDMO is responsible for steering the company's strategic direction, overseeing critical operational processes, and ensuring financial stability. Comprising top executives, including the CEO, CFO, and other senior VPs, this team drives key initiatives across scientific development, supply chain management, regulatory compliance, and human resources to maintain operational excellence and achieve organizational goals in the pharmaceutical development and manufacturing industry.

Leadership Team

Scientific Research and Development

Engineering

Leadership Team

About

Team members

Other teams at Societal™ CDMO

Scientific Research and Development

Engineering